Lv1
100 积分 2024-02-29 加入
Novel drug targets in 2025
1小时前
已完结
Dupilumab: Advances in the off‐label usage ofIL4/IL13antagonist in dermatoses
6天前
已完结
The Efficacy of Off-Label Dupilumab in Cutaneous Amyloidosis
6天前
已完结
Cancer Research Communications
11天前
已完结
Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial
3个月前
已完结
TL1A: A New Potential Target in the Treatment of Inflammatory Bowel Disease
3个月前
已完结
Biogenesis and engineering of interleukin 12 family cytokines
3个月前
已完结
Inflame and restrain — the paradoxical roles of IL-12 and IL-23 in immunity
3个月前
已完结
Whole-Genome Sequencing IdentifiesSTAT4as a Putative Susceptibility Gene in Classic Kaposi Sarcoma
3个月前
已完结
Developmental cell programs are co-opted in inflammatory skin disease
4个月前
已完结
皖公网安备34019202002308
